15-Jan-2015 - Andrew Lloyd & Associates

CiToxLAB announces the appointment of Dr. Philippe Ancian as Senior Director of Biomarkers

CiToxLAB announces that it has hired Dr. Philippe Ancian as Senior Director of Biomarkers for the group. Philippe has fostered a 20-year career in the development of biomarkers and specialized genomics and proteomics platforms.

Philippe Ancian has a PhD in molecular and cellular biology. He was Head of Biomarkers at Laboratoires Galderma, then Director of Research and Development for the pharma business unit at Protéus before joining CiT in 2005 to develop the functional genomics platform at the Evreux site (France). He then moved to Transgène in 2010 as Senior Director of the Vectorology and Biomarkers departments, to work on strategy definition and to conduct follow-ups on biomarker and immunomonitoring studies in relation to clinical trials from phases I to III.

Facts, background information, dossiers
  • CiToxLAB
  • appointments
More about CiToxLAB
  • News

    Charles River Laboratories to acquire French CRO

    Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing adjustments. The proposed transaction is expected to close i ... more

    Citoxlab acquires Solvo Biotechnology

    Citoxlab Group announced that it has entered into a definitive agreement to acquire Solvo Biotechnology. The closing of this operation will take place within the next month. Financial details were not disclosed. Through this new acquisition Citoxlab reinforces its position in the non-clinic ... more